CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CGEM stock results show that Cullinan Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

The post CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.

More From InvestorPlace

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”